Previous close | 16.20 |
Open | 16.20 |
Bid | 18.70 |
Ask | 20.30 |
Strike | 45.00 |
Expiry date | 2024-09-20 |
Day's range | 16.20 - 16.20 |
Contract range | N/A |
Volume | |
Open interest | 4 |
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...